Increased immunoreactivity of stromal cell-derived factor-1 and angiogenesis in asthma

European Respiratory Journal

Volumn 21, Issue 5, 2003, Pages 804-809

  Hoshino, M ^a   Aoike, N ^b   Takahashi, M ^b   Nakamura, Y ^b   Nakagawa, T ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Airway remodelling; Airway vascularity; Angiogenesis; Stromal cell derived factor 1

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHEMOATTRACTANT; COLLAGEN TYPE 4; CORTICOSTEROID DERIVATIVE; METHACHOLINE; STROMAL CELL DERIVED FACTOR 1;

ANGIOGENESIS; ARTICLE; ASTHMA; BRONCHUS BIOPSY; BRONCHUS HYPERREACTIVITY; BRONCHUS MUCOSA; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FIBEROPTIC BRONCHOSCOPY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MACROPHAGE; NEOVASCULARIZATION (PATHOLOGY); NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY TRACT MUCOSA; SPIROMETRY; SUBMUCOSA; T LYMPHOCYTE;

ADOLESCENT; ADULT; ASTHMA; CHEMOKINES, CXC; FEMALE; HUMANS; MALE; NEOVASCULARIZATION, PATHOLOGIC; RESPIRATORY MUCOSA;

EID: 0038056259     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.03.00082002     Document Type: Article

References (29)

1. Dunnill MS. The pathology of asthma with special reference to changes in the bronchial mucosa. J Clin Pathol 1960; 13: 27-33.
2. Kuwano K, Bosken CH, Pare PD, Bai TR, Wiggs BR, Hogg JC. Small airways dimensions in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 1993; 148: 1220-1225.
3. Carroll NG, Cooke C, James AL. Bronchial blood vessel dimensions in asthma. Am J Respir Crit Care Med 1997; 155: 689-695.
4. Li X, Wilson JW. Increased vascularity of the bronchial mucosa in mild asthma. Am J Respir Crit Care Med 1997; 156: 229-233.
5. Vignola AM, Kips J, Bousquet J. Tissue remodeling as a feature of persistent asthma. J Allergy Clin Immunol 2000; 105: 1041-1053.
6. Hoshino M, Takahashi M, Aoike N. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J Allergy Clin Immunol 2001; 107: 295-301.
7. Bleul CC, Farzan M, Choe H, et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 1996; 382: 829-833.
8. Tachibana K, Hirota S, Iizasa H, et al. The chemokine receptor CXCR4 is essential for vascularisation of the gastrointestinal tract. Nature 1998; 393: 591-594.
9. Zou Y-R, Kottmann AH, Kuroda M, Taniuchi I, Littman DR. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 1998; 393: 595-599.
10. Nagasawa T, Hirota S, Tachibana K, et al. Defects of B-cell lymphopoiesis and bone- marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 1996; 382: 635-638.
11. National Institute of Health. National Asthma Education and Prevention Program: Guideline for the diagnosis and management of asthma. NIH Publication No. 97-4051. Bethesda, MD, National Institutes of Health, 1997.
12. Takishima T, Hida W, Sasaki H, Suzuki S, Sasaki K. Direct-writing recorder of the dose-response curves of the airway to methacholine. Chest 1981; 80: 600-606.
13. Ishii M, Hida W, Suzuki S, Ichinose M, Sasaki H, Takishima T. Comparison of intermittent and continuous inhalation provocation tests. Ann Allergy 1989; 62: 223-228.
14. Bentley AM, Menz G, Robinson DS, Bradley B, Jeffery PK, Durham SR. Identification of T lymphocyte, macrophages, and activated eosinophils in the bronchial mucosa of intrinsic asthma: relationship to symptoms and bronchial hyperresponsiveness. Am Rev Respir Dis 1992; 145: 500-506.
15. Moqbel R, Ying S, Barkans J, et al. Identification of messenger RNA for IL-4 in human eosinophils with granule localization and release of the translated product. J Immunol 1995; 155: 4939-4947.
16. Orsida BE, Li X, Hickey B, Thien F, Wilson JW, Walters EH. Vascularity in asthmatic airways: relation to inhaled steroid dose. Thorax 1999; 54: 289-295.
17. Salvato G. Quantitative and morphological analysis of the vascular bed in bronchial biopsy specimens from asthmatic and non-asthmatic subjects. Thorax 2001; 56: 902-906.
18. Rongish BJ, Hinchman G, Doty MK, Baldwin HS, Tomanek RJ. Relationship of the extracellular matrix to coronary neovascularisation during development. J Moll Cell Cardiol 1996; 28: 2203-2215.
19. Vrugt B, Wilson S, Bron A, Holgate ST, Djukanovic R, Aalbers R. Bronchial angiogenesis in severe glucocorticoid-dependent asthma. Eur Respir J 2000; 15: 1014-1021.
20. Chu HW, Kraft M, Rex MD, Martin RJ. Evaluation of blood vessels and edema in the airways of asthma patients. Regulation with clarithromycin treatment. Chest 2001; 119: 416-422.
21. Hoshino M, Takahashi M, Takai Y, Sim J, Aoike N. Inhaled corticosteroids decrease vascularity of the bronchial mucosa in patients with asthma. Clin Exp Allergy 2001; 31: 722-730.
22. Salcedo R, Wasserman K, Young HA, et al. Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells. Am J Pathol 1999; 154: 1125-1135.
23. Fedyk ER, Jones D, Critchley HOD, Phipps RP, Blieden TM, Springer TA, Expression of stromal-derived factor-1 is decreased by IL-1 and TNF and in dermal wound healing. J Immunol 2001; 166: 5749-5755.
24. Gupta SK, Lysko PG, Pillarisetti K, Ohlstein E, Stadel JM. Chemokine receptors in human endothelial cells. Functional expression of CXCR4 and its transcriptional regulation by inflammatory cytokines. J Biol Chem 1998; 273: 4282-4287.
25. Feil C, Augustin HG. Endothelial cells differentially express functional CXC-chemokine receptor-4 (CXCR-4/fusin) under the control of autocrine activity and exogenous cytokines. Biochem Biophys Res Commun 1998; 247: 38-45.
26. Volin MV, Joseph L, Shockley MS, Davies PF. Chemokine receptor CXCR4 expression in endothelium. Biochem Biophys Res Commun 1998; 242: 46-53.
27. Hoshino M, Nakamura Y, Hamid QA. Gene Expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma. J Allergy Clin Immunol 2001; 107: 1034-1038.
28. Gonzalo J-A, Lloyd CM, Peled A, Delaney T, Coyle AJ, Gutierrez-Ramos J-C. Critical involvement of the chemotactic axis CXCR4/Stromal cell-derived factor-1α in the inflammatory component of allergic airway disease. J Immunol 2000; 165: 499-508.
29. Pablos JL, Amara A, Bouloc A, et al. Stromal-cell derived factor is expressed by dendritic cells and endothelium in human skin. Am J Pathol 1999; 155: 1577-1586.